Pay in 4 interest-free payments of $7.14 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Obesity is a serious medical condition with real health impacts
Gynecomastia risk Breast tissue development represents one of the more concerning potential side effects, particularly because gynecomastia can become permanent if excessive tissue growth occurs
The glucagon receptor activation appears to contribute to quicker metabolic response, while the GIP component may help reduce early nausea that can slow initial adaptation to GLP-1 medications
Who its for May be a fit if you Want the FDA-approved brand-name semaglutide specifically Are exploring provider-guided weight management Prefer a once-weekly injection pen Want licensed provider oversight and ongoing support Not appropriate if you Have a personal or family history of medullary thyroid carcinoma or MEN 2 Are pregnant, trying to conceive, or breastfeeding Have a history of pancreatitis or certain GI conditions (discuss with your provider) Are advised against GLP-1 care by your provider Eligibility is always determined by a licensed provider after reviewing your intake
Pairing Emsculpt with Semaglutides We have found many patients who are on this class of medication injections to have significantly decreased muscle mass that even results in skin laxity
